Apretude (cabotegravir long-acting injectable)

Many patients pay $0 through manufacturer patient assistance programs. Contact our pharmacists — we handle all the paperwork.

Apretude is the first FDA-approved long-acting injectable PrEP medication. A healthcare provider administers two injections two months apart, then one injection every two months — no daily pills needed. It contains cabotegravir, a powerful integrase inhibitor.

Our pharmacists coordinate with your prescribing provider to deliver injections on schedule and manage any insurance or financial assistance needs.

• Every-2-month injectable — no daily pills
• Injections given by a healthcare provider
• Full insurance coordination and patient assistance
• Ideal for patients who struggle with daily adherence